A Prospective, Randomized Controlled Phase II Clinical Study Evaluating the Efficacy and Safety of Endostar Combined With AI Regimen Compared With AI Regimen in Adjuvant Treatment After Radical Resection of Recurrent Soft Tissue Sarcoma
Latest Information Update: 04 Sep 2023
At a glance
- Drugs Doxorubicin (Primary) ; Endostatin (Primary) ; Ifosfamide (Primary) ; Mesna (Primary)
- Indications Fibroma; Haemangiosarcoma; Leiomyosarcoma; Liposarcoma; Malignant fibrous histiocytoma; Myxoid liposarcoma; Nerve sheath neoplasms; Sarcoma; Soft tissue sarcoma; Synovial sarcoma
- Focus Therapeutic Use
- 11 Jan 2021 New trial record